Royalty Pharma Stock (NASDAQ: RPRX) stock price, news, charts, stock research, profile.
You can purchase shares of Royalty Pharma (NASDAQ:RPRX) through any online brokerage.
Other companies in Royalty Pharma’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).
Royalty Pharma has a consensus price target of $45.38.
The stock price for Royalty Pharma (NASDAQ: RPRX) is $25.23 last updated December 24, 2024 at 1:00 PM EST.
A quarterly cash dividend of 0.21 per share of Class A Common Stock. The quarterly cash dividend was payable on December 10, 2024 to stockholders of record on November 15, 2024.
Royalty Pharma’s Q4 earnings are confirmed for Thursday, February 13, 2025.
There is no upcoming split for Royalty Pharma.
Royalty Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.